Clinical Trials Sponsored by Reckitt Benckiser Pharmaceuticals Inc.

Total 10 results

Reckitt Benckiser Inc.

Completed

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Healthy Subjects
Reckitt Benckiser Inc.

Completed

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

Healthy Subjects
Reckitt Benckiser Inc.

Completed

Mucinex Exploratory Cold Study

Common Cold

United States
Reckitt Benckiser Inc.

Completed

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI (Wait and See)

Acute Upper Respiratory Track Infection

United States
Reckitt Benckiser Inc.

Completed

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers

Healthy Subjects
Reckitt Benckiser Inc.

Completed

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.

Healthy Subjects
Indivior Inc.
Reckitt Benckiser LLC

Completed

Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)

Opioid Dependency
Reckitt Benckiser LLC
Premier Research Group plc; Aptuit Inc.

Completed

Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study

Post-operative Pain

United States
University of North Carolina, Chapel Hill
Reckitt Benckiser Inc.

Completed

Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung

Mucociliary Clearance

United States
Pfizer
Novartis; Boehringer Ingelheim; Reckitt Benckiser LLC; Procter and Gamble; Perrigo... and other collaborators

Terminated

Acute Cough Study In Children

Common Cold | Infections, Upper Respiratory Tract

United States

3

Subscribe